Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Drug Trials Snapshots: PALSONIFY | FDA
Oral Acromegaly Pill PALSONIFY Sustains Two-Year IGF-1 Control in New ...
Vertex to Acquire Crinetics for $10 Billion, Adding PALSONIFY and Phase ...
Crinetics outlines 2026 pipeline expansion and targets PALSONIFY as ...
New acromegaly drug, Palsonify from Crinetics, wins FDA approval | STAT
Crinetics Posts Strong PALSONIFY Debut, Beating Revenue and EPS ...
Crinetics Announces Strong PALSONIFY Launch Execution and Positive ...
Crinetics shares jump on robust PALSONIFY uptake and encouraging trial ...
Crinetics Q2 Earnings: $1.2B Cash, PALSONIFY FDA Decision Due September ...
PALSONIFY (Paltusotine): A Landmark Palsonify FDA Approval for ...
Palsonify (paltusotine): Uses, Side Effects, Dosage & Reviews
Acromegaly's Next Frontier: Crinetics' PALSONIFY Aims to Overhaul ...
Palsonify (Paltusotine): Uses, Side Effects, Interactions, Pictures ...
Crinetics gets first FDA approval as Palsonify is cleared for rare ...
Crinetics Pharmaceuticals Reports the US FDA’s Approval of Palsonify ...
Room for growth in acromegaly as Crinetics’ Palsonify cleared | BioWorld
Big News for Acromegaly: Crinetics Announces FDA Approval of PALSONIFY ...
Crinetics Pharmaceuticals’ Palsonify Gains Positive Endorsement for ...
Test Your Knowledge on Palsonify for the Treatment of Acromegaly
New Oral Therapy for Acromegaly: FDA Approves Palsonify (Paltusotine ...
Why PALSONIFY is the BEST Treatment for Acromegaly Patients Today ...
FDA Approves Palsonify for Acromegaly Treatment
Crinetics' PALSONIFY Gets FDA Approval as First Oral Acromegaly Drug ...
Palsonify Receives FDA Approval for Treatment of Adults with Acromegaly ...
Crinetics' Q3 2025: Contradictions Emerge on PALSONIFY Launch ...
Crinetics reports robust full-quarter sales for rare disease drug Palsonify
Palsonify - RxNorm Crosswalk NDC 84015-930
Palsonify Tablet Supplier in India | Indian Pharma Network
Vertex Pharmaceuticals to Acquire Crinetics for $10 Billion, Deepening ...
Vertex Pharmaceuticals Acquires Crinetics for $10B, Expanding ...
Vertex Acquires Crinetics Pharmaceuticals to Expand Rare Disease ...
Lower Keys Medical Center is nationally recognized for its commitment ...
Disgraced Amisfield chef comes to personify the Govt-backed Michelin ...
Is Crinetics Pharmaceuticals, Inc. (CRNX) Stock Positioned for Growth ...
Crinetics highlights Palsonify, atumelnant at ENDO 2026 | CRNX Stock News
In a full circle moment of Druski’s “Being American Skit” and American ...
Crinetics Pharmaceuticals (CRNX) Is Up 6.9% After Promising Phase 2 ...
Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the ...
Vertex's $10 Billion Crinetics Bet: Real Pipeline Boost or Stretch for ...
Vertex sees over $5 billion peak sales potential from Crinetics assets
Vertex buys Crinetics for $10 billion in rare-disease push
VertexがCrineticsを約100億ドルで買収を発表、Palsonifyとatumelnantで成長を狙う | ウクライナニュース ...
When great men stand up & choose to invest in their people great things ...
Vertex (VRTX) Stock: $10B Crinetics Deal Expands Rare Disease Pipeline
Vertex to buy Crinetics for $10 billion, diversifying beyond cystic ...
Burna Boy and Ademola Lookman meet in Portugal.🇵🇹🇳🇬🤩🔥 As influential ...
VRTX to strengthen rare disease portfolio with $10B Crinetics buyout
Crinetics Pharmaceuticals, Inc.: Crinetics Presents Long Term Data at ...
Vertex's $10B Crinetics Bid: Break the CF Ceiling or Buy Expensive Hope?
Vertex Is Buying Crinetics for $10 Billion. Here's What Investors Need ...
Vertex Eyes Expansion Beyond Cystic Fibrosis with Planned $10B ...
Palsonify™ Demonstrates Durable Acromegaly Control in Long-Term Data
Crinetics stocks surge after Vertex agrees to $10B cash buyout
9 Best Mental Health Software in 2026: My Top Picks - Behavioral ...
CrinetiCARE: PALSONIFY™ Patient Assistance Program
LucyRx and Personify Health Join Forces to Tackle Rising Employer GLP-1 ...
3 residents personify hardships many still face after Hurricane Ida
Boston Globe / Getty Images
PALSONIFY™ (paltusotine) FDA Approved for Acromegaly | HCP
He survived Battle of the Bulge and went on to personify Greatest ...
Momentive Software Accelerates Mission-Driven Innovation with Strategic ...
Coach Replacement Index 2026: Which Coaches Will AI Replace? | Personify
MOA and Dosing for PALSONIFY™ (paltusotine) | HCP
nudge E-Guide – Personify Health Dell
Crinetics Wins FDA Approval for PALSONIFY, the First Once-Daily Oral ...
Crinetics Pharma Surges After FDA OKs Its Treatment For Growth Disorder
Vertex拟以约100亿美元收购Crinetics，获得Palsonify并扩展罕见病布局 | 乌克兰新闻 - #Mezha
FDA Approves Paltusotine (Palsonify) As First Once-Daily, Oral ...
DailyMed - PALSONIFY- paltusotine tablet, film coated
Crinetics receives FDA approval for Palsonify, a daily oral treatment ...
PALSONIFY™ (paltusotine) - Orsini
Crinetics Debuts Palsonify™: A New Dawn for Acromegaly Care - Investors ...
FDA Approves PALSONIFY™ (Paltusotine) as First Oral Therapy Drug for ...
Crinetics' PALSONIFY: A Disruptive Breakthrough in Acromegaly Treatment?
Crinetics to Showcase PALSONIFY™ and Atumelnant Results at ENDO 2025
Crinetics | Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine ...
PALSONIFY™ (paltusotine), FDA-Approved for Treatment of Adults with ...
Can Wockhardt Hit ₹2,000? SEBI RA Vijay Gupta Sees Potential As US ...
Momentive Software Acquires Personify, Creating 37,000-Client ...
Virgin Pulse and HealthComp Introduce Combined Company as Personify Health
Personify Health | Personalized Health Platform
For a clinicians perspective we talk with Dr. Kevin Yuen about ...
Palsonify, an Oral Therapy for Acromegaly, Gets FDA Approval ...
Paltusotine (Palsonify) - Market Movers of 2026
Personify Health Market Comparison Analysis
US FDA Approves Palsonify, First Once-Daily Oral Pill for Rare Hormonal ...
FDA Approves Palsonify: 1st Oral Acromegaly Breakthrough
Personify Health | Formerly Virgin Pulse | #1 Wellness Platform
Import Personify MC Professional User with its Type or Groups & Assign ...
The Advent of Oral Somatostatin Receptor Agonists: A Clinical and ...
FDA Approves Palsonify: First Once-Daily Pill for Acromegaly in Adults
New Acromegaly Drug Taken Once Monthly Changes Treatment ...
.png)
